Articles from Caixin Global, Caixin Global

Caixin Global

Caixin is a media group dedicated to providing financial and business news through periodicals, online content, mobile apps, conferences, books and TV/video programs. Caixin aims to blaze a trail that helps traditional media prosper in the new media age through integrated multimedia platforms.

Articles from Caixin Global

News from Caixin

Equity Bottom-Up

Northeast Pharmaceutical A / Equity Bottom-Up

<ul><li>Leading Chinese drug-ingredients supplier Northeast Pharmaceutical Group Co. Ltd. was fined 133 million yuan ($19 million) for abusing its dominant market position in materials used to make a treatment for kidney dialysis patients.</li><li>The market regulator in northeastern China’s Liaoning province conducted a three-year investigation of Northeast Pharmaceutical’s monopoly in the market for ingredients to make levocarnitine.</li><li>The medicine is used to treat dialysis patients for a lack of carnitine, a substance that helps the body convert fat into energy</li></ul>

Leading Chinese drug-ingredients supplier Northeast Pharmaceutical Group Co. Ltd. was fined 133 million yuan ($19 million) for abusing its dominant market position in materials used to make a treatment for kidney dialysis patients.The market regulator in northeastern China’s Liaoning province conducted a three-year investigation of Northeast Pharmaceutical’s monopoly in the market for ingredients to make levocarnitine.The medicine is used to treat dialysis patients for a lack of carnitine, a substance that helps the body convert fat into energy

Northeast Pharmaceutical Fined $19 Million for Jacking Up Drug Ingredient Prices